|
Model Number 37602 |
Device Problems
Disconnection (1171); High impedance (1291); Insufficient Information (3190)
|
Patient Problems
Muscular Rigidity (1968); Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id 3389-40 lot# j0211638v serial# implanted:
(b)(6) 2002 explanted: product type lead product id 37602 lot# serial# (b)(6) implanted: (b)(6) 2019 explanted: product type implantable neurostimulator product id neu_unknown_ext lot# serial# unknown implanted: explanted: product type extension.Information references the main component of the system.Other relevant device(s) are: product id: 3389-40, serial/lot #: j0211638v, ubd: 16-apr-2006, udi#: (b)(4) ; product id: neu_unknown_ext, serial/lot #: unknown, ubd: 16-apr-2006, udi#:.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that the impedances are out of range.The unipolar impedances are all >5000ohms and the bipolar impedances are between 995 - 3536 ohms.Technical services (ts) reviewed that it is most likely that the extension came out of the ins socket.The provider replaced the implanted device and the impedances remained the same.During investigation, additional information received from the manufacturer¿s representative (rep) reported they reviewed previous impedances and dating back to 2020 impedances had been out of range.The patient mentioned they felt things may have been ¿off¿ since the beginning.The rep mentioned the patient was symptomatic (rigid and stiff) so it was unknown if they had been getting therapy or not.Images and impedance testing was reviewed which appeared the lead became disconnected from the extension therefore it was likely fluid/tissue had ingressed into the distal end of the extension causing the expected impedance measurements so that the monopolar path gave a reading as opposed to just over 40,000 ohms (but this wasn¿t confirmed).It was reviewed that while the bipolar measurements are ¿in range¿ they were still suspect given the imaging and what was occurring with monopolar pairs.It was unknown what was going to happen next as they were waiting for neurologist/neurosurgeon for further steps.
|
|
Event Description
|
Additional information was received from a manufacturer representative (rep) reporting that the event has not been resolved.They are scheduling extension replacement for january.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the manufacturer representative.Patient is scheduled for extension replacement today due to the impedance issue.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 3389-40 lot# j0211638v implanted: (b)(6) 2002: product type lead product id 37602 lot# serial# (b)(6) implanted: (b)(6) 2019 product type implantable neurostimulator.Product id neu_unknown_ext product type extension.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the manufacturer¿s representative (rep) reported impedances resolve during the lead revision, however the target was incorrect so no stimulation could be provided to side effects at low ma.
|
|
Search Alerts/Recalls
|
|
|